Profound Medical Hosts Insightful Prostate Treatment Event
Company Announcements

Profound Medical Hosts Insightful Prostate Treatment Event

Story Highlights

Profound Medical (TSE:PRN) has released an update.

Profound Medical Corp recently held their ‘PRO-Talk Live!’ event, attracting physicians to discuss the TULSA-PRO technology for prostate disease treatment. Key opinion leaders and experts provided insights on using TULSA-PRO, while Siemens Healthineers and Cook Medical endorsed a shared vision with Profound for a comprehensive MR solution in prostate disease management.

For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyProfound Medical reports Q3 EPS (38c), consensus (30c)
TipRanks Auto-Generated NewsdeskProfound Medical Sees Strong Growth with TULSA-PRO®
TipRanks Canadian Auto-Generated NewsdeskProfound Medical’s TULSA Gains CMS Reimbursement Boost
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App